FOLFIRI-Aflibercept combination a new light of hope for Colorectal cancer patients following a failed oxaliplatin-based chemotherapy Colorectal cancer (CRC) is the third most common invasive tumor, and one of few cancers to show a progressive and steady increase worldwide, with more than 1.5 million cases registered annually, basic risk factors include changes in the dietary…… Read More »


© 2024 Medcoi LLC, all rights reserved.
go to top